中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
24期
11432-11435
,共4页
张邓新%王向兵%季永%高烨
張鄧新%王嚮兵%季永%高燁
장산신%왕향병%계영%고엽
昂丹司琼%麻醉%手术后恶心呕吐%剖宫产术
昂丹司瓊%痳醉%手術後噁心嘔吐%剖宮產術
앙단사경%마취%수술후악심구토%부궁산술
Ondansetron%Anesthesia%Postoperative nausea and vomiting%Cesarean section
目的:观察5-羟色胺3受体拮抗剂昂丹司琼对腰硬联合麻醉下剖宫产术中及术后不同原因恶心呕吐的防治效果。方法择期及急诊剖宫产手术患者280例,随机分为对照组和昂丹司琼组,每组140例;昂丹司琼组在夹闭脐静脉即刻静脉注射昂丹司琼8 mg,对照组注射生理盐水4 ml,观察术中、术后恶心呕吐的发生率。结果与对照组相比,昂丹司琼组不但术中恶心呕吐总发生率显著下降(P<0.05),饱胃患者恶心呕吐发生率降低(P<0.05);而且术后恶心呕吐总发生率也显著下降(P<0.05),使用PCEA患者中、重度恶心呕吐发生率明显减少(P<0.05)。结论昂丹司琼可有效防治饱胃患者的术中恶心呕吐,同时可有效减少PCEA患者术后恶心呕吐的发生。
目的:觀察5-羥色胺3受體拮抗劑昂丹司瓊對腰硬聯閤痳醉下剖宮產術中及術後不同原因噁心嘔吐的防治效果。方法擇期及急診剖宮產手術患者280例,隨機分為對照組和昂丹司瓊組,每組140例;昂丹司瓊組在夾閉臍靜脈即刻靜脈註射昂丹司瓊8 mg,對照組註射生理鹽水4 ml,觀察術中、術後噁心嘔吐的髮生率。結果與對照組相比,昂丹司瓊組不但術中噁心嘔吐總髮生率顯著下降(P<0.05),飽胃患者噁心嘔吐髮生率降低(P<0.05);而且術後噁心嘔吐總髮生率也顯著下降(P<0.05),使用PCEA患者中、重度噁心嘔吐髮生率明顯減少(P<0.05)。結論昂丹司瓊可有效防治飽胃患者的術中噁心嘔吐,同時可有效減少PCEA患者術後噁心嘔吐的髮生。
목적:관찰5-간색알3수체길항제앙단사경대요경연합마취하부궁산술중급술후불동원인악심구토적방치효과。방법택기급급진부궁산수술환자280례,수궤분위대조조화앙단사경조,매조140례;앙단사경조재협폐제정맥즉각정맥주사앙단사경8 mg,대조조주사생리염수4 ml,관찰술중、술후악심구토적발생솔。결과여대조조상비,앙단사경조불단술중악심구토총발생솔현저하강(P<0.05),포위환자악심구토발생솔강저(P<0.05);이차술후악심구토총발생솔야현저하강(P<0.05),사용PCEA환자중、중도악심구토발생솔명현감소(P<0.05)。결론앙단사경가유효방치포위환자적술중악심구토,동시가유효감소PCEA환자술후악심구토적발생。
Objective To observe the efficacy of intravenous 5-hydroxytryptamine 3 receptor antagonist in the prevention of nausea and vomiting while and after cesarean section (CS). Methods A total of 280 pregnant women with American Society of Anesthesiologists (ASA) Physical Status Ⅰ-Ⅱ who underwent emergency and elective CS under combined spinal-epidural anesthesia (CSEA) were randomly divided into two groups (n=140):in clamping the umbilical vein immediately intravenous ondansetron 8 mg (ondansetron group) or 0.9% normal saline 4 ml (control group) were intravenously infused, respectively. The episodes of nausea and vomiting intraoperatively and postoperatively were observed. Results In ondansetron group, the incidence of intra- and post-operative nausea and vomiting reduced significantly compared with the control group, and the incidences of intraoperative severe nausea and vomiting in full stomach patients of ondansetron group were 6.5%, which were significantly lower than that in control group. The incidences of postoperative moderate and severe nausea and vomiting patients who using PCEA of ondansetron were significantly lower than that in control group (P<0.05). Conclusion Ondansetron has better treatment for intra- and post-operative nausea and vomiting caused by full stomach and PCEA.